Skip to main content

Table 3 Primary outcomes

From: The MOVE-trial: Monocryl® vs. Vicryl Rapide™ for skin repair in mediolateral episiotomies: a randomized controlled trial

 

Monocryl (n = 64)

Vicryl rapide (n = 67)

p-value

VAS* 24 h sitting

6.0 ± 2.4

5.9 ± 2.4

0.80

VAS 24 h walking

5.1 ± 2.5

4.9 ± 2.5

0.72

VAS 24 h lying down

3.9 ± 2.5

3.2 ± 2.3

0.09

VAS 10 days sitting

2.8 ± 2.5

2.5 ± 2.1

0.43

VAS 10 days walking

2.1 ± 2.1

2.4 ± 2.4

0.48

VAS 10 days lying

1.5 ± 1.9

1.2 ± 1.6

0.24

VAS 6 weeks sitting

0.5 ± 1.2

0.5 ± 1.3

0.73

VAS 6 weeks walking

0.5 ± 1.0

0.3 ± 1.0

0.24

VAS 6 weeks lying

0.3 ± 0.7

0.2 ± 0.8

0.74

VAS 3 months sitting

0.06 ± 0.2

0.09 ± 0.6

0.60

VAS 3 months walking

0.06 ± 0.2

0.09 ± 0.4

0.67

VAS 3 months lying

0.03 ± 0.2

0.03 ± 0.2

0.97

  1. Variables are given as means with standard deviations (± SD) and p-values. *Visual Analogous Scale (0-10 cm)
Back to article page

BMC Pregnancy and Childbirth

ISSN: 1471-2393

Contact us